Quit Conference - 2020

Expert Smoking Cessation Training

This site is intended only for healthcare professionals or Other Relevant Decision Makers.

Start Date:
10th November 2020

Start Time:12:00 GMT

Pfizer CHAMPIX (varenicline tartrate) Promotional Meeting

CHAMPIX UK Prescribing Information

Adverse Event Reporting

This 1.5 hour webinar will allow healthcare professionals or other relevant decision makers to hear from world renowned experts in smoking cessation, who will:
• Assess the quit smoking landscape and the impact of COVID-19
• Review current clinical evidence on smoking cessation
• Offer training on approaching quit conversations in-person and during virtual consultations

All participants will have the opportunity to be actively involved in the webinar through interactive Q&As.


Dr. Alex Bobak

GP Specialist in Smoking Cessation, Wandsworth Medical Centre, London, UK

Alex is senior partner of a General Practice in South London. He has been running specialist stop smoking clinics since 2001 and was the first GP with Special Interests (GPSI) in smoking cessation in the United Kingdom. His main interests are the optimization of smoking cessation delivery and the education of healthcare professionals in the subject. He has carried out research into both as well as into pharmacological treatments to stop smoking. Working on a chest ward as a junior doctor led him to become a passionate campaigner on how to stop smoking and he believes that helping smokers to stop is a most important part of medical care. To that end, he has pioneered the practical interventions Very Brief Advice (VBA) and Brief Support and Treatment (BST) to help time pressured doctors deliver smoking cessation interventions. He lectures and teaches on smoking cessation throughout the UK and abroad.

Professor Serena Tonstad

Head Physician, Oslo University Hospital, Oslo, Norway

Serena Tonstad is Head Physician at Oslo University Hospital, Department of Preventive Cardiology and a Professor at Loma Linda University. She has dedicated her career to preventive care in patients with lifestyle related disorders including tobacco addiction, lipid disorders and obesity. She is actively involved in research in these areas and has more than 300 peer-reviewed publications to her credit. Her main research interests are the prevention and epidemiology of cardiovascular disease and treatment of tobacco addiction. She is involved in working with primary care and specialist physicians in tobacco cessation interventions.

Professor Keir Lewis

Professor of Respiratory Medicine, Swansea University & Consultant Physician

Keir Lewis trained in London and Wales UK. He is a Professor of Respiratory Medicine in Swansea University, a practising pulmonologist and Medical Director of Respiratory Innovation Wales. Keir set-up the Smoking Cessation Service for his group of hospitals in 2004 and still leads it. He is also a clinical lead for smoking cessation specialists within hospitals covering 3.2 million people in Wales and advises Welsh & UK governments on smoking research and policy. Professor Lewis has chaired the British Thoracic Society Tobacco Advisory Group, written two text books, various book chapters and papers on smoking cessation and tobacco control. He has lectured worldwide and co-authored UK and European Guidelines on smoking cessation. He is the lead or co-applicant on research grants worth over £15M. He researches chronic lung disease and is the Chief Investigator on the largest prospective study worldwide on stopping smoking after a diagnosis of lung cancer (LungCast). In his spare time, he uses his lungs to play saxophone.

Register Today
Please enter the required information to register for this webinar.

First Name:
Last Name:
Email Address:
Job Title:

By clicking “Register”, you confirm that you are a healthcare professional and that the information you have provided above is correct. You consent to Pfizer’s processing of your personal data for the purpose of communication related to this event, including its transfer internally and to third parties, in accordance with the Pfizer Policy and to AMI processing your personal data in accordance with AMI Privacy Policy.

Pfizer CHAMPIX (varenicline tartrate) Promotional Meeting.
This promotional meeting is organized and funded by Pfizer. Discussion of smoking cessation treatments will include Pfizer products, including CHAMPIX.
CHAMPIX Prescribing InformationPrivacy PolicyTerms of Use

PP-CHM-GBR-3398 | September 2020Adverse events should be reported. Reporting forms and information can be found at www.mhra.gov.uk/yellowcard or search for MHRA Yellow Card in the Google Play or Apple App Store. Adverse events should also be reported to Pfizer Medical Information on 01304 616161.